Latest news in Cannabis.

FDA Simplifies Compassionate Use of Experimental Drugs, But Medical Marijuana Is Tricky

FDA Simplifies Compassionate Use of Experimental Drugs, But Medical Marijuana Is Tricky.

  • A company calling itself High Times Travel LLC (hightimestravel.com) has illegally infringed on the HIGH TIMES trademark to sell travel packages for the upcoming US Cup in Seattle.
  • FDA Simplifies Compassionate Use of Experimental Drugs, But Medical Marijuana Is Tricky
  • Although medical marijuana – among the safest alternative treatments in the world – qualifies for the federal government’s compassionate use program in states that have legalized the herb as part of its Right to Try law, terminally ill patients living in states like Indiana, which does not even have a modest medical marijuana program in place, will have a difficult time using the law to gain access to cannabis because it only certifies the use of experimental, non-FDA-approved medications that are currently involved in at least the initial phase of clinical trails.
  • Use our medical marijuana directory to find dispensaries and medicine in your area.

Read the full article, click here.


@HIGH_TIMES_Mag: “FDA Simplifies Compassionate Use of Experimental Drugs, But Medical Marijuana Is Tricky.”


The U.S. Food and Drug Administration recently announced a new compassionate use policy intended to make it easier for physicians to submit the necessary paperwork to gain access to experimental drugs for patients inflicted with serious or immediately life-threatening conditions for which there are no other treatments available. 


FDA Simplifies Compassionate Use of Experimental Drugs, But Medical Marijuana Is Tricky

Comments are closed, but trackbacks and pingbacks are open.

Subscribe To Personalized Notifications

You are subscribing to jobs matching your current search criteria.

Email Notifications

Email notifications will be sent to you Subscribe

 

Custom RSS Feed

Your personalized RSS Feed is below, copy the address to your RSS reader. Subscribe